New York Proton Center is a clinical research site located in New York, New York, United States 10035.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Proton Center has participated in 13 clinical trials with 13 currently active.
Therapeutic areas: Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7.
Sponsors: M.D. Anderson Cancer Center, NRG Oncology, Massachusetts General Hospital.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Proton Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Proton Center has 13 clinical trials on record, with 13 currently active. Their work covers Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7.
Yes — New York Proton Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.